NBI-1117568 trials for Schizophrenia

All NBI-1117568 trials · All Schizophrenia trials

Phase breakdown

Recruiting trials studying NBI-1117568 for Schizophrenia

• Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
  NCT07227818 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 20 locations
• NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
  NCT06963034 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 21 locations
• NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
  NCT07105098 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 15 locations
• NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
  NCT07114874 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 57 locations

Common questions

How many trials study NBI-1117568 for Schizophrenia?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.